MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Cognitive functioning in Parkinson’s disease and Parkinson plus syndrome

    S. Mina, V.K. Verma, K.S. Anand (New Delhi, India)

    Objective: Our study aimed to investigate and compare the cognitive functioning in PD and PPS. Background: Parkinson[s] disease (PD) is now known to be associated…
  • 2016 International Congress

    Clinical and instrumental features of multiple system atrophy with laryngeal stridor

    M. Todisco, R. Zangaglia, B. Minafra, M. Terzaghi, E. Alfonsi, P. Vitali, C. Pacchetti (Pavia, Italy)

    Objective: To evaluate clinical and instrumental different features in two case series of multiple system atrophy (MSA) patients with or without laryngeal stridor. Background: MSA…
  • 2016 International Congress

    Defining the pathology underlying cortico-basal syndrome: A European study

    R.C. Lamb, M.C. Darvell, J.D.S. Woodside, J.D. Rohrer, A.J. Lees, H.R. Morris (London, United Kingdom)

    Objective: To understand how clinical and biological features can help us define and explain the varying pathology that underlies corticobasal syndrome (CBS). Background: Corticobasal degeneration…
  • 2016 International Congress

    Health-related quality of life of multisystem atrophy and progressive supranuclear palsy patients

    M. Figura, L. Milanowski, B. Kierdaszuk, A. Bartoszek, P. Janik, Z. Jamrozik (Warsaw, Poland)

    Objective: The aim of our study was to describe how different aspects of daily living and health related quality of life (HRQoL) are impaired by…
  • 2016 International Congress

    Initial clinical description of progressive supranuclear palsy in the Luxembourg Parkinson’s study

    P. Kolber, G. Hipp, M. Kerschenmeyer, K. Roomp, S.K. Mosch, L. Longhino, A. Schweicher, M. Faltz, V.P. Satagopam, N. Goncharenko, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Krüger (Esch-sur-Alzette, Luxembourg)

    Objective: To characterize the clinical features and prevalence of patients with progressive supranuclear palsy (PSP) in the recently implemented longitudinal Parkinson's cohort (HELP-PD). Background: PSP…
  • 2016 International Congress

    Low cerebrospinal fluid 3,4-dihydroxyphenylacetic acid and 3,4-dihydroxyphenylglycol levels are biomarkers of Parkinsonian disorders, including PSP

    A. Stefani, C. Holmes, E. Olivola, Y. Sharabi, D. Goldstein (Rome, Italy)

    Objective: To assess whether Progressive Sopranuclear Palsy (PSP) patients show, in CSF an alteration of catecholamine metabolites. Background: It was reported previously that, consistent with…
  • 2016 International Congress

    Triple stimulation technique findings in patients with Parkinson’s disease and multiple system atrophy

    H. Wang, Q. Ding, J. Yuan, L. Cui (Beijing, People's Republic of China)

    Objective: This study aims to evaluate the cortico-spinal tract impairment in PD and multiple system atrophy (MSA) Parkinsonian variant using triple stimulation technique (TST). Background:…
  • 2016 International Congress

    Clinical phenotype (motor and neuropsychological presentation) and neuroimaging in Sardinian patients affected by atypical parkinsonisms, carriers of 20-22 repeats of C9ORF72 hexanucleotide expansion

    G. Orofino, A. Cannas, P. Solla, M.M. Mascia, M.R. Murru, G. Borghero (Monserrato, Italy)

    Objective: Based on our previous finding of the p.A382T of TARDBP in patients with concomitant parkinsonism in the Sardinian population, we hypothesized that also the…
  • 2016 International Congress

    Parkinson’s syndrome as possible manifestation of lamina quadrigemina tumor or inflammation

    N.M. Pavlyshyna, I.V. Khubetova (Odessa, Ukraine)

    Objective: Objective of this report is to discuss the case of Parkinson's syndrome (PS) in 22 y.o. patient on the background of the pathological process…
  • 2016 International Congress

    Diagnostic value of cardiac 123I-MIBG SPECT and CT co-registration in PD and MSA-P

    C. Kaindlstorfer, F. Krismer, A. Fanciulli, S. Eschlböck, M. Nocker, S. Bösch, K. Mair, C. Scherfler, A. Djamshidian-Tehrani, C. Uprimny, E. Donnemiller, I. Virgolini, K. Seppi, W. Poewe, G. Wenning (Innsbruck, Austria)

    Objective: The aim of this study was to determine the diagnostic accuracy of cardiac 123I-metaiodobenzylguanidine (MIBG)-SPECT and CT co-registration in discriminating the Parkinson variant of…
  • « Previous Page
  • 1
  • …
  • 1550
  • 1551
  • 1552
  • 1553
  • 1554
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley